Oral administration of "Infectvac" for prevention of acute respiratory tract infections
Luther, P.; Brachmann, I.; Werchan, D.; Wittig, C.; Tischner, H.
Zeitschrift für Erkrankungen der Atmungsorgane 175(2): 95-99
1990
ISSN/ISBN: 0303-657X PMID: 2264367 Document Number: 362901
The efficacy of a newly developed polyvalent bacterial lysat vaccine "Infectvac" was tested in experimental studies in animals. It was shown that a local application (oral, aerogenic) prevent the animals from a lethal bacterial (S. pneumoniae) or viral (A/PR/8/34) infection. In first clinical trials a good compatibility of the drug was demonstrated.